MarketPulse

degenerative disc disease

3 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Fibrobiologics, Inc.

FibroBiologics Advances Clinical Pipeline With cGMP Manufacturing, Raises $3M

FibroBiologics completes cGMP manufacturing for lead candidate CYWC628, expects first patient dosing Q2 2026 in diabetic foot ulcer trial. Company raises $3M and maintains $1.5M cash.
FBLGcapital raisepreclinical results
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Mesoblast Hits Recruitment Milestone in Pivotal Back Pain Trial

Mesoblast completes recruitment of 300+ patients in pivotal Phase 3 trial for chronic back pain therapy, targeting mid-2027 results and Q3 2027 FDA filing.
MESOPhase 3 clinical trialFDA approval
GlobeNewswire Inc.GlobeNewswire Inc.··Na

BioRestorative Closes $5M Equity Offering to Fund Stem Cell Pipeline

BioRestorative raised $5M through equity offering to advance stem cell therapies, including BRTX-100 for spine disease and metabolic disorder research.
BRTXclinical trialsregenerative medicine